Zealand Pharma A/S (CPH:ZEAL)
Denmark flag Denmark · Delayed Price · Currency is DKK
448.00
+2.60 (0.58%)
Sep 5, 2025, 4:59 PM CET

Zealand Pharma Statistics

Total Valuation

Zealand Pharma has a market cap or net worth of DKK 31.53 billion. The enterprise value is 15.35 billion.

Market Cap31.53B
Enterprise Value 15.35B

Important Dates

The last earnings date was Thursday, August 14, 2025.

Earnings Date Aug 14, 2025
Ex-Dividend Date n/a

Share Statistics

Zealand Pharma has 70.38 million shares outstanding. The number of shares has increased by 18.37% in one year.

Current Share Class 70.38M
Shares Outstanding 70.38M
Shares Change (YoY) +18.37%
Shares Change (QoQ) +1.58%
Owned by Insiders (%) 0.32%
Owned by Institutions (%) 50.08%
Float 59.90M

Valuation Ratios

The trailing PE ratio is 4.78.

PE Ratio 4.78
Forward PE n/a
PS Ratio 3.46
PB Ratio 2.02
P/TBV Ratio 2.02
P/FCF Ratio 4.19
P/OCF Ratio 4.18
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 2.13, with an EV/FCF ratio of 2.04.

EV / Earnings 2.30
EV / Sales 1.69
EV / EBITDA 2.13
EV / EBIT 2.14
EV / FCF 2.04

Financial Position

The company has a current ratio of 15.09, with a Debt / Equity ratio of 0.03.

Current Ratio 15.09
Quick Ratio 15.08
Debt / Equity 0.03
Debt / EBITDA 0.06
Debt / FCF 0.05
Interest Coverage 224.24

Financial Efficiency

Return on equity (ROE) is 53.44% and return on invested capital (ROIC) is 34.83%.

Return on Equity (ROE) 53.44%
Return on Assets (ROA) 32.86%
Return on Invested Capital (ROIC) 34.83%
Return on Capital Employed (ROCE) 44.76%
Revenue Per Employee 21.49M
Profits Per Employee 15.76M
Employee Count335
Asset Turnover 0.67
Inventory Turnover n/a

Taxes

In the past 12 months, Zealand Pharma has paid 534.00 million in taxes.

Income Tax 534.00M
Effective Tax Rate 7.40%

Stock Price Statistics

The stock price has decreased by -47.29% in the last 52 weeks. The beta is 0.60, so Zealand Pharma's price volatility has been lower than the market average.

Beta (5Y) 0.60
52-Week Price Change -47.29%
50-Day Moving Average 376.78
200-Day Moving Average 539.39
Relative Strength Index (RSI) 68.22
Average Volume (20 Days) 365,922

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Zealand Pharma had revenue of DKK 9.11 billion and earned 6.68 billion in profits. Earnings per share was 93.68.

Revenue9.11B
Gross Profit 9.12B
Operating Income 7.19B
Pretax Income 7.21B
Net Income 6.68B
EBITDA 7.20B
EBIT 7.19B
Earnings Per Share (EPS) 93.68
Full Income Statement

Balance Sheet

The company has 16.58 billion in cash and 396.95 million in debt, giving a net cash position of 16.18 billion or 229.90 per share.

Cash & Cash Equivalents 16.58B
Total Debt 396.95M
Net Cash 16.18B
Net Cash Per Share 229.90
Equity (Book Value) 15.61B
Book Value Per Share 221.77
Working Capital 15.89B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 7.54 billion and capital expenditures -14.31 million, giving a free cash flow of 7.53 billion.

Operating Cash Flow 7.54B
Capital Expenditures -14.31M
Free Cash Flow 7.53B
FCF Per Share 106.97
Full Cash Flow Statement

Margins

Gross margin is 100.06%, with operating and profit margins of 78.88% and 73.34%.

Gross Margin 100.06%
Operating Margin 78.88%
Pretax Margin 79.20%
Profit Margin 73.34%
EBITDA Margin 78.98%
EBIT Margin 78.88%
FCF Margin 82.64%

Dividends & Yields

Zealand Pharma does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -18.37%
Shareholder Yield n/a
Earnings Yield 21.19%
FCF Yield 23.88%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Zealand Pharma has an Altman Z-Score of 21.97 and a Piotroski F-Score of 6.

Altman Z-Score 21.97
Piotroski F-Score 6